Stockreport

New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF Expanded EBLIS study with up to 12 years of clinical follow-up across all subtypes of breast cancer AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a glo [Read more]